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We have expressed the recombinant reverse transcriptase (RT) of bovine leukemia virus (BLV) in bacteria. The gene
encoding the RT was designed to start at its 59 end next to the last codon of the mature viral protease, namely the amino
terminus of the RT matches the last 26 codons of the pro gene and is coded for by the pro reading frame. The RT sequence
extends into the pol gene, utilizing the pol reading frame after overcoming the stop codon by adding an extra nucleotide (thus
imitating the naturally occurring frameshift event). Hence we have generated a transframe polypeptide that is a 584-residues-
long protein (see Rice, Stephens, Burny, and Gilden (1985) Virology 142, 357–377). This protein was partially purified after
adding a six-histidine tag and studied biochemically testing a variety of parameters. The enzyme exhibits all activities typical
of RTs, i.e., both RNA- and DNA-dependent DNA polymerase as well as a ribonuclease H (RNase H) activity. Unlike most RTs,
the BLV RT is enzymatically active as a monomer even after binding a DNA substrate. The enzyme shows a preference for
Mg21 over Mn21 in both its DNA polymerase and RNase H activities. BLV RT is relatively resistant to nucleoside triphosphate
analogues, which are known to be potent inhibitors of other RTs such as that of HIV. © 1999 Academic Press
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Bovine leukemia virus (BLV) is a naturally occurring
xogenous B-cell lymphotropic retrovirus. This infectious
irus is the etiological agent of enzootic cattle leukosis,
haracterized by an initial persistent lymphocytosis,
hich is followed by the occurrence of clonal lymphoid
-cell tumors after a long latency (Ghysdael et al., 1985).
LV can infect in vitro a variety of cells and can propa-
ate in different animal species. It is distantly related to
he human lymphotrophic viruses type I and type II
HTLV-1 and HTLV-2, respectively), forming a subfamily of
ransactivating retroviruses (Coffin, 1996). These com-
lex retroviruses contain at their 39 end of genome the
egulatory genes tax and rex. The presence of both Rex
nd Tax proteins are required for viral replication (Green
nd Chen, 1994; Kettmann et al., 1994). These viruses
lso show nucleotide sequence similarities. Neverthe-
ess, BLV and HTLVs do not infect the same cell types
ecause they probably bind different cell receptors.
The process of reverse transcription is the major early
ntracellular event that is critical to the life cycle of all
etroviruses. This stage in the synthesis of the proviral
ouble-stranded DNA is catalyzed by a single viral en-
yme, the reverse transcriptase (RT). The plus-strand
iral RNA is copied by the RNA-dependent DNA polymer-
se (RDDP) activity of RT, producing RNA z DNA hybrids.
oncurrently with this DNA synthesis, the intrinsic
1 To whom reprint requests should be addressed. Fax: 972–3-
f407432. E-mail: ahizy@ccsg.tau.ac.il.
042-6822/99 $30.00
opyright © 1999 by Academic Press
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176Nase H activity of RT specifically hydrolyzes the RNA in
hese heteroduplexes. Finally, the plus-strand DNA is
ynthesized by copying the first DNA strand by the DNA-
ependent DNA polymerase (DDDP) activity of RT (with
ragments of the original viral RNA serving as primers for
NA synthesis of the second DNA strand) (Skalka and
off, 1993; Coffin et al., 1997). The pivotal role of RT in the
ife cycle of retroviruses has made it a major target for
he development of RT inhibitors as antiretroviral drugs
De Clercq, 1995; Coffin et al., 1997). The molecular,
tructural, and catalytic properties of retroviral RTs have
een the focus of numerous recent studies, including
hree-dimensional crystal studies (e.g., Kohlstaedt et al.,
992; Jacobo Molina et al., 1993; Georgiadis et al., 1995;
uang et al., 1998). A major effort was devoted to the
esearch of the RTs of the human immunodeficiency
iruses type 1 and type 2 (HIV-1 and HIV-2, respectively),
he viruses responsible for acquired immunodeficiency
yndrome (AIDS) because most anti-AIDS drugs ap-
roved so far for the treatment of this disease are inhib-
tors of the viral RT. Because of the rapid emergence of
rug-resistant HIV RT variants, the development of novel
otent and specific inhibitors of HIV RT is still a chief
oal in the chemotherapy of AIDS. Targeted drug de-
igns depend on a better understanding of the general
tructure and function of retroviral RTs. Therefore the
nvestigation of RTs of other retroviruses is very likely to
xpand our understanding of the catalytic properties of
hese closely related proteins.
Almost all research on the structure and enzymaticeatures of RTs was done on the recombinant proteins
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177RECOMBINANT BOVINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASExpressed in large amounts in bacteria. BLV RT has not
een expressed as a recombinant enzymatically active
rotein, and there are only very few reports with a partial
haracterization of the RT activity in virions of BLV (Gil-
en et al., 1975; Mamoun et al., 1981; Demirhan et al.,
996). Therefore it was of interest to express recombi-
ant BLV RT and to study its biochemical properties. We
eport here on such a study. When the outlined research
f BLV RT was already underway, two very recent reports
ere published on the recombinant expression of the RT
TLV-1, which is closely related to BLV (Owen et al.,
998; Trentin et al., 1998). This allowed us to compare the
trategies of cloning the RT-expressing genes and the
asic features of the various RTs. The comparison, dis-
ussed below, reveals basic differences between the
ecombinant BLV RT and either one of the two recombi-
ant RTs of HTLV-1 as well as between the two HTLV-1
T species.
RESULTS
xpression of enzymatically active BLV RT
Rationale. The translation of retroviral reverse tran-
criptases is a relatively complex process because in
ost retroviruses it involves either one or two frameshift-
ng events. The first reading frame of the genomic RNA,
hich serves as a messenger RNA, encodes for the
olyprotein precursor of the Gag proteins. A Gag-Pro-
ease polyprotein precursor is synthesized as a result of
vercoming the stop codon at the end of the gag gene by
frameshift event at the 21 direction. In BLV, a second
rameshifting event is necessary to allow the synthesis of
he Gag-Pro-Pol polyprotein precursor, which serves
lso as a precursor for the Pol-related enzymes, the RT
nd integrase (IN) (Jacks, 1990; Coffin et al., 1997). The
ctual amino acid sequences at the carboxyl and amino
ermini of the virus-purified RTs have served as a lead for
esigning the gene coding for recombinant RTs (e.g., Hizi
nd Hughes, 1988; Hizi et al., 1988). In the absence of
uch sequence information, sequence homologies to
ther known RTs were also used as a guide for the
esign of RT-coding genes (e.g., Hizi et al., 1991a; Sha-
arabany et al., 1993). The carboxyl terminus of the
rotease of all retroviruses studied so far was found to
e next to the amino terminus of the RT. Hence another
pproach, employed in the strategy of planning the BLV
T-encoding gene in the present study, was to deduce
he amino terminus of the protein from the carboxyl
erminus of the protease, assuming that the two are
djacent as in other retroviruses.
The sequence analysis of the virus-purified BLV pro-
ease and its comparison with the nucleotide sequence
f BLV genome (Rice et al., 1985; Yoshinaka et al., 1986)
ndicates that the codon for the last carboxyl terminal
esidue of the mature viral protease is located at the 26th Todon upstream to the 39 end of the pro open reading
rame. Therefore based on the assumption that the
mino terminus of the RT is adjacent to the carboxyl
erminus of the protease, the amino terminus of the RT is
redicted by us to be H2N-Val-Leu-Asp-Ala-Pro- encoded
y nucleic acid sequence starting in the pro gene at
osition 2055 in the published BLV sequence (Rice et al.,
985). Consequently, BLV RT is expected to be a trans-
rame protein. A similar approach was employed recently
n designing the amino terminus of recombinant HTLV-1
T (Trentin et al., 1998). The frameshift site in BLV RT was
redicted to be after codon 26 at 21 direction based on
he consensus for retroviral frameshift sites (Hatfield et
l., 1992), allowing the translation of the rest of the
rotein from the pol open reading frame. The carboxyl
erminus of the BLV RT was predicted based on both
omology to termini of other RTs as well as on the
utative protease cleavage site. This sequence is -Thr-
ro-Glu-Gln-Trp-COOH (corresponding to the sequence
hat ends in nucleotide 3805 in the BLV sequence). In all,
he recombinant RT is expected to be 584-amino-acid
esidues long (Fig. 1A). To substantiate the selection of
he right carboxyl terminus, we have also expressed an
T–IN fused protein, which ends at the natural integrase
top codon (starting at position 4667) and has a total
ength of 871 residues. This recombinant protein showed
DNA polymerase activity comparable to that of the
84-long RT (data not shown). Therefore we have as-
umed that there are no significant truncations at the
arboxyl terminus, and hence our initial prediction of the
equence of this terminus is quite right.
Vector constructions. The overall strategy of the vector
onstruction is described schematically in Fig. 1B. All
NA fragments were synthesized in vitro by PCR as
escribed under Materials and Methods. The frameshift-
ng event required for the expression of BLV RT does not
ormally occur in bacteria and certainly not in the posi-
ion appropriate for the synthesis of authentic RT in the
nfected mammalian cells. Therefore as performed re-
ently by us for the expression of MMTV RT (Taube et al.,
998), we have mutated the RT-encoding gene. This was
one by adding an extra cytosine downstream to the
equence TTTAAAC, which codes for the RNA transla-
ional frameshift site (between nucleotides 2132 and
133 in the BLV genome). This procedure necessitated
he initial PCR amplification of the RT-coding gene as two
eparate DNA fragments with some overlapping in one
f which an additional dC was introduced (Fig. 1B).
The first DNA fragment (corresponding to nucleotides
055–2465 in the BLV genome) was PCR-amplified using
59 end primer with an NcoI site, which introduces an
nitiation methionine adjacent to the sequence coding for
he amino terminus of BLV RT (H2N-Val-Leu-Asp-Ala-Pro-)
PCR1). The 39 end primer matched the sequences of the
LV RT genome followed by an HindIII restriction site.
he DNA fragment was cleaved with NcoI and HindIII
o
l
T
pFIG. 1. Schematic description of the strategy and method of cloning the BLV RT-encoding gene into the pUC12N expression vector. (A) Presentation
f the retroviral gene coding for BLV RT. The length of the polypeptide fragments are marked by the numbers of the residues. We have used the single
etter codes for the amino acid sequences. (B) The method of constructing the BLV RT-expressing vector. The methodology is detailed under ‘‘Results’’.
he blackened boxes represent sequences not present in the original BLV genome which were added by the PCR. The numbering of all nucleotide
ositions are those of the BLV genome according to Rice et al. (1995).
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179RECOMBINANT BOVINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASEnd subcloned into the pUC12N plasmid cleaved by the
ame restriction enzymes, generating a plasmid entitled
BLV RTf (see Materials and Methods). The second DNA
ragment was PCR-synthesized using a 59 end primer
hat introduced an extra C between nucleotides 2132 and
133 (PCR 2). The 39 end primer matched the BLV ge-
ome sequence up to nucleotide 3805, followed by a
ranslation termination codon and an HindIII restriction
ite. The DNA fragment (;1750 bp long), which overlaps
n its 59 end the 39 end of the first PCR-synthesized BLV
T DNA fragment, was cut by KpnI and HindIII. The
verlapping sequence contains a KpnI site at the se-
uence corresponding to position 2111. Therefore the
leaved fragment was introduced into the KpnI- and
indIII-cleaved plasmid harboring the first DNA segment
pBLV RTf), generating the final expression vector, pBLV
T (see Fig. 1B).
The DH5a bacteria transformed with the right plasmid
ere tested for the overexpression of BLV RT by check-
ng the presence of the recombinant protein in whole cell
ysates using SDS–PAGE analysis and by monitoring the
oly(rC)n z oligo(dG)12–18 -directed polymerase activity in
acterial extracts (see Materials and Methods). The
coI–HindIII 1758-bp DNA inserts from positive clones
ere subcloned into pUC112N6H plasmid, the expres-
ion vector with the six-histidine tag sequence (see Ma-
erials and Methods).
urification of the recombinant BLV RT
The bacterial clones harboring the pUC112N6H RT-
xpressing plasmid (see above) were examined for the
evel of RT activity and analyzed by SDS–PAGE. There
as a polypeptide protein band with an apparent molec-
lar weight of ;65 kDa that was not present in control
scherichia coli with a plasmid without the BLV RT gene
nsert (not shown). This molecular weight is compatible
ith a recombinant protein, which is 584 residues (plus
ix histidines and one methionine) long. The protein was
urified by a fast purification method taking advantage of
he presence of the six-histidine tag. Previous experi-
nces with a variety of retroviral RTs have shown that
ecombinant RTs, tagged with six-histidine residues at
ither amino or carboxyl termini, are as active as the
ounterpart RT molecules with no histidine tags (unpub-
ished results). Therefore there was no need to remove
hese extra sequences from the purified BLV RT. The
urification procedure, employing Ni–NTA agarose affin-
ty chromatography followed by a CM–Sepharose ion
xchange chromatography, was described in detail un-
er Materials and Methods. The typical quantitative pu-
ification is summarized in Table 1.
The first purification step resulted in a substantial
ncrease (183-fold) in the specific activity of RT, accom-
anied by a 2.7-fold increase in the total activity relative po that of the crude lysate. The second purification step
esulted in an additional considerable increase in the
pecific activity (of ;90-fold). Altogether, there is an
verall 73-fold increase in the total DNA polymerase
ctivity throughout the whole purification process,
trongly suggesting the removal of potent RT inhibitors.
imilarly, in the purification process of recombinant
MTV RT, both column chromatography steps led to
ncreases in the total RT activity, suggesting also removal
f inhibitors in both steps (Taube et al., 1998). Unfortu-
ately, unlike previous purifications of recombinant RTs
ith similar columns (including that of MMTV RT), an
DS–PAGE analysis of BLV RT revealed significant
mounts of contaminating proteins (data not shown).
ence we conclude that despite the high increase in the
pecific activity of the RT (of ;16,380-fold), the final
reparation of the BLV RT used was only partially pure.
ll contaminating protein polypeptides were bound to
he Ni–NTA column, although proteins from lysates of
ontrol bacteria (prepared by the same extraction
ethod) were shown not to bind to such columns (data
ot shown). Therefore we assume that the contaminating
roteins are either of bacterial origin and were bound to
he column via the histidine-tagged BLV RT molecules
by interacting with them noncovalently) and/or that pro-
eolytically cleaved BLV RT-derived polypeptides bind the
olumn via the retained histidine-tagged amino terminus.
partial support for the latter alternative might be the
act that most contaminating polypeptides were with
pparent molecular weights smaller than the 65-kDa
ull-length BLV RT polypeptides and that other recombi-
ant RTs were shown to be quite sensitive to bacterial
TABLE 1
Quantitative Summary of the Purification of Recombinant BLV RT
Purification step
Total
protein
(mg)
Total DNA
polymerase
activity
(units)
Specific DNA
polymerase activity
(units/mg protein)
rude bacterial
extract
152 3.2 3 103 2.1 3 101 (1)
i–NTA agarose
column eluate
2.24 8.6 3 103 3.84 3 103 (183)
M–Sepharose
column eluate
0.68 234 3 103 344 3 103 (16,380)
Note. The DNA polymerase activity is expressed in pmoles of
3H]dGTP incorporated into the TCA-insoluble material in 30 at 37°C in
he poly(rC)n z oligo(dG)12–18-directed reactions as described under Ma-
erials and Methods. The different purification steps are described also
nder Materials and Methods. Protein concentrations were determined
sing bovine serum albumin as a protein standard (Bradford, 1976). The
igures in parenthesis are the fold of increase in the specific activity of
he purified protein relative to that of the crude bacterial lysate.roteases. This issue of the source of the contaminating
p
m
S
s
c
p
e
w
w
t
e
i
D
m
t
d
e
c
a
B
p
F
a
1
m
f
n
s
o
a
o
p
m
a
m are ind
180 PERACH AND HIZIroteins, their possible association with BLV RT, and
ethods to remove them will be studied in the future.
ubunit composition of the catalytically active BLV-RT
Most RTs studied so far are heterodimers, where the
maller subunits are derived from the larger ones by a
leavage toward their carboxyl termini by the retroviral
rotease (Skalka and Goff, 1993; Coffin et al., 1997). One
xception is the RT of murine leukemia virus (MLV),
hich is composed of monomers of ;71 kDa, although it
as suggested that the enzyme dimerizes after binding
he DNA substrate (Telesnitsky and Goff,1993). A second
xception is the recently studied MMTV RT. Here, the RT
s a 66-kDa monomer even after binding to its cognate
NA substrate (Taube et al., 1998).
FIG. 2. Determination of the molecular size of the enzymatically acti
f 20–35% (v/v) glycerol were prepared in 30 mM Tris–HCl, 0.1 M NaCl
s described in detail previously (Hizi and Joklik, 1977; Taube et al., 19
ligonucleotides. The preparation sequences and preincubation cond
reviously (see Taube et al., 1998, Fig. 3). Molecular size markers w
olecular mass 16.9 kDa (measured by A410nm); bacterial alkaline phosp
s a substrate at A405nm) HIV-1 RT, molecular mass 110 kDa (assayed
ass ;150 kDa. The positions of the peaks of these marker proteinsThe purified BLV RT was analyzed from the molecular uass of the enzymatically active protein, employing ul-
racentrifugation through glycerol gradients under non-
enaturating conditions along with known protein mark-
rs with known molecular masses (Fig. 2). We have
onfirmed that the gradient conditions preserved the
uthentic subunit pattern of RTs by testing, in addition to
LV RT, the sedimentation pattern of heterodimeric p66/
51 HIV-1 RT (molecular mass of ;110 kDa). As shown in
ig. 2, the DNA polymerase activity of BLV RT sediments
s a single peak located between the myoglobin (M.W.
6.9 kDa) and alkaline phosphatase (AP) (M.W. 86 kDa)
arkers. The sedimentation of HIV-1 RT is substantially
aster, between the alkaline phosphatase and the immu-
oglobulin G (IgG) (M.W. 150 kDa) markers. This strongly
uggests that BLV RT is a monomeric enzyme in solution
RT by ultracentrifugation through glycerol gradients. Linear gradients
riton X-100, 20 mg/ml BSA, and 5 mM DTT, centrifuged, and analyzed
) Free BLV RT. (n) BLV RT bound to double-stranded 48mer synthetic
of the BLV RT with these synthetic DNA were also described by us
alyzed in parallel centrifuge tubes. These markers were: myoglobin,
(AP), molecular mass 86 kDa (assayed using p-nitrophenyl phosphate
routine BLV RT RDDP assay), and immunoglobulin G(IgG), molecular
icated by arrows.ve BLV
, 0.2% T
98). (F
itions
ere an
hatase
by thender conditions where HIV-1 RT is a dimer. Because it
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181RECOMBINANT BOVINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASEas reported that monomeric MLV RT dimerizes in so-
ution after binding to the DNA substrate, we have also
xamined whether the recombinant BLV RT shows a
imilar feature. Consequently, we have incubated the
LV RT with a molar excess of double-stranded oligo-
eric DNA prior to the sedimentation analysis. The RT
ound to DNA also sediments as a monomer. It should
e noted that the RT–DNA complex sediments faster
han free monomeric RT, a phenomenon that can be
xplained by the additional mass of the DNA in the
T–DNA complex (48 bp long) and/or by a difference in
he folding of the RT after binding the DNA. This supports
he notion that all the RT molecules were bound to the
NA substrate. The behavior of BLV RT shown in Fig. 2
s practically indistinguishable from the behavior of mo-
omeric MMTV RT because the complex of monomeric
MTV RT–DNA sedimented faster than the free mono-
eric RT (see Fig. 3 in Taube et al., 1998).
he relative DNA polymerase and RNase H activities
f BLV RT
All RTs studied so far are multifunctional, possessing
DDP, DDDP, and RNase H activities (Hizi et al., 1977,
991b; Hizi and Yaniv, 1980; Skalka and Goff, 1993; Ru-
inek et al., 1994; Taube et al., 1998). We have tested the
urified BLV RT for all activities using a variety of polynu-
leotide substrates commonly suitable for assaying RT
ctivities. Furthermore the divalent cation (Mg12 vs Mn12)
reference was checked for each substrate (Table 2). As
or the DNA synthesis, of all substrates tested poly(rA)n z
ligo(dT)12–18 is the most efficient one. This finding is
ompatible with the substrate preference of most RTs
tudied (Skalka and Goff, 1993). Similar to other RTs, the
ubstrate that is considered the most specific for RT-
irected DNA polymerase, poly(29-O-methylC)n z oli-
o(dG)12–18, is the least efficient relative to all other sub-
trates studied. Of substrates employed for assaying the
DDP activity, poly(dC)n z oligo(dG)12–18 is shown to be the
ost efficient substrate, even higher than the RNA z DNA
ounterpart substrate, poly(rC)n z oligo(dG)12–18. The re-
ombinant BLV RT has also a significant RNase H activity
ith the synthetic substrate [3H]poly(rA)n z poly(dT)n,
hich is the most commonly used for assaying this
ctivity.
Most DNA polymerases including all RTs are strictly
ependent on the presence of divalent cations. Most RTs
refer Mg12 over Mn12 with the most outstanding excep-
ion are the RTs of mammalian type C retroviruses, such
s MLV RT, which prefers Mn12. The BLV RT displays for
ll its catalytic activities a marked preference for Mg12
ver Mn12 (Table 2). The ratio between the Mg12- and
n12-dependent activities varies with the substrate and
ctivity assayed. Thus the highest ratio is observed in the
DDP assay with poly(rA)n z oligo(dT)12–18 (;12-fold) and she lowest one is detected in the RNase H activity (of
12-fold).
H optimum for the catalytic activities of BLV RT
We have determined the dependence of the BLV RT
atalytic activities on the pH of the reaction mixtures (Fig.
). The DDDP exhibited a relatively wide range of pH
ependence peaking at pH 7.0–8.0. The RDDP activity is
ore sensitive to lowering the pH than the DDDP. Both
DDP and DDDP functions are relatively insensitive to
igh pH values; thus only 40% of the activity was lost at
H 10. The pH-dependence curve for the RNase H ac-
ivity is more symmetric with a sharper peak at around
H 8.0. At both pH 7.0 and 9.0, the activity drops to ;60%
f the highest one at pH 8.0.
inetic constants of the DNA polymerase activities of
LV RT
To study the steady-state kinetic parameters of the
ecombinant BLV RT, we have calculated the Km values
or both RDDP and DDDP activities. These constants
ere derived from the double reciprocal curves of the
nitial velocities as a function of substrate concentrations
Table 3). The Km values for the RDDP activity were
alculated for dGTP and dTTP [in the poly(rC)n z oli-
o(dG)12–18- and poly(rA)n z oligo(dT)12–18-directed DNA
TABLE 2
Catalytic Activities, Substrate Specificities, and Divalent Cation
Preference of BLV RT
Activity Substrate
Specific
activities (pmole
per mg protein)
Mg12 Mn12
DDP Poly(rA)n z oligo(T)12–18 1077.4 90.7
Poly(rC)n z oligo(dG)12–18 397.3 77.6
Poly(29-O-methylC)n z oligo(dG)12–18 59.1 21.1
DDP Poly(dA)n z oligo(dT)12–18 29.1 8.5
Poly(dC)n z oligo(dG)12–18 528.2 74.8
Activated DNA 71.2 19.2
Nase H [3H]poly(rA)n z poly(dT)n 7.1 2.1
Note. The specific activities are expressed either in pmoles dNTP
ncorporated into the nascent DNA strands (for DNA synthesis, namely
DDP and DDDP) or in pmoles [3H]dAMP released from the substrate
in the case of RNase H), in 30 min at 37°C. Activated DNA was
repared as described under Materials and Methods. In the assay with
his template, the dNTP incorporation was calculated for all dNTPs
ncorporated, assuming equimolar incorporation. All synthetic tem-
late z primers were at final concentrations of 5 mg/ml. The reactions
ere conducted in the presence of either 8 mM MgCl2 or 1 mM MnCl2.
ll values presented are averages of at least two independent exper-
ments, after subtracting the background levels with no RT present in
he assay tubes. The standard deviations for all results were usually
0% of the average values presented.ynthesis, respectively] and for the two synthetic prim-
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182 PERACH AND HIZIrs. The Km values for the DDDP activity were calculated
ith activated DNA (prepared as described under Mate-
ials and Methods) for both dGTP and dTTP. It is appar-
nt from Table 3 that the Km values calculated for BLV RT
re comparable with the values reported for the RTs of
MTV, EIAV, HIV-1, and HIV-2 (Hizi et al., 1991b; Rubinek
t al., 1994; Taube et al., 1998).
FIG. 3. The effects of pH on the catalytic activities of BLV RT. The RDD
nd Methods by varying the pH values. For reactions performed at pH 6
sed; 25 mM glycine-NaOH was used for pH values 9.0–10. Enzymatic v
F) DDDP, () RNase H
TABLE 3
The Km Values for dNTPs and Template-Primers Calculated
for BLV RT in the DNA Polymerase Reactions
Activity
Km (mg/ml)
dTTP dGTP
Poly(rA)n z
oligo(T)12–18
Poly(rC)n z
oligo(dG)12–18
RDDP 9.4 6 1.4 9.8 6 1.0 4.8 12.7
DDDP 2.0 6 0.6 1.9 6 0.5 N.A. N.A.
Note. The Km values were determined from the double-reciprocal
lots of the varied substrate concentrations against the initial rates of
NA synthesis. The plots were computer-generated by linear regres-
ion analyses. Assays were conducted as described under Materials
nd Methods. For RDDP activity, dTTP was assayed with poly(rA)n z
ligo(dT)12–18, whereas dGTP was assayed with poly(rC)n z oligo(dG)12–18.
he template-primer used for the DDDP activity was activated DNA.
K (mM)mh.A., not applicable.nhibition of the DNA polymerase activities by
ucleoside analogues
All RTs exhibit some sensitivity to nucleoside analogue
nhibitors that serve as DNA chain terminators. This
ensitivity varies, depending on the RT studied, on the
utants of every given RT and on the inhibitors tested.
hus such drugs are being used successfully for the
reatment of HIV infections in humans, e.g., 39 azido-29,39
ideoxythymidine (AZT), 29,39-dideoxyinosine (ddI), and
2)-29-deoxy-39-thiacytidine (3TC). These nucleoside an-
logues are potent inhibitors of the RTs of HIV-1 and
IV-2 (De Clercq, 1995). There are, however, frequent
mergences of drug resistance to these inhibitors by
utating these RTs (Skalka and Goff, 1993; Coffin et al.,
997). We have assayed BLV RT in the presence of the
hain terminator ddGTP ddTTP and AZTTP, which are
nown to be potent competitive inhibitors of the RTs of
IV-1, HIV-2, and MMTV. It is apparent that these ana-
ogues inhibit both the RDDP and DDDP activity of BLV
T with the former activity much more sensitive to these
ompounds (Table 4). However, when the IC50 values
alculated for BLV RT are compared with those of the
IV-1, HIV-2, and MMTV, it is clear that this novel recom-
inant enzyme is substantially less sensitive to the in-
P, and RNase H assays were conducted as described under Materials
25 mM sodium acetate was used; for pH 6.5–9.0 25, mM Tris–HCl was
re expressed as percentages of maximal activity observed. (E) RDDP,P, DDD
.0–6.5,
alues aibitors. In this regard, BLV RT is closer to the more
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183RECOMBINANT BOVINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASEesistant RT of equine infectious anemia virus (EIAV),
hich despite being a lentivirus, shows distinct differ-
nces from HIV RTs (Hizi et al., 1991b; Rubinek et al.,
994; Taube et al., 1998).
nhibition of the catalytic functions of BLV RT
The effects of NaCl and KCl on the enzymatic activities
f BLV RT. Most RTs studied require NaCl or KCl at final
oncentrations of 50–100 mM for their optimal activities
f both DNA polymerase and RNase H. We have shown
ecently that MMTV RT is quite sensitive to these salt
oncentrations, and the highest levels of activities are
btained when assayed with no monovalent cations
resent (Taube et al., 1998). Therefore it was of interest to
est also the effects of NaCl and KCl on BLV RT. The
esults shown in Fig. 4A, show that BLV RT is quite
ensitive to the presence of NaCl and KCl in all catalytic
unctions. Of the DNA polymerase activities, the RDDP
ctivity is slightly more susceptible (with an IC50 value of
60 mM) than the DDDP activity (IC50 of ;90 mM). The
Nase H is sensitive as is the RDDP. In addition there is
ery little difference between the response to NaCl com-
ared with KCl. In all, BLV RT is quite similar to MMTV RT
n its high susceptibility to salts.
Involvement of cysteine residues in the enzymatic ac-
ivities of BLV RT. Most RTs studied so far were shown to
e sulfhydryl-requiring enzymes, namely, reduced cys-
eine groups participate in forming the functionally active
atalytic sites (Skalka and Goff, 1993). The exception to
his rule are the RTs of HIV-1 and HIV-2, where the DNA
olymerase functions are fully resistant to thiol reagents
although the RNase H activity is highly sensitive to these
eagents). In the present study, we have tested the sen-
itivity of the enzymatic activities of BLV RT to the sulf-
ydryl-specific reagent N-ethylmaleimide (NEM). Previ-
TABLE 4
Inhibition of the RDDP and DDDP Activities of BLV RT
by dNTP Analogues
Enzymatic
activity
Inhibitor (IC50 values in nM)
ddGTP ddTTP AZTTP
RDDP 20 6 4 86 6 2 80 6 4.3
DDDP 3900 6 200 860 6 61 1050 6 90
Note. The increasing dNTP analogs were tested by using increasing
oncentrations of each chain terminator—RDDP activity was assayed
ith either poly(rA)n z oligo(dT)12–18 and dTTP (for the inhibitors dTTP and
ZTTP) or poly(rC)n z oligo(dG)12–18 and dGTP for the analogue ddGTP.
DDP was assayed with activated DNA and all four dNTPs for all three
nalogues. In all cases, we have observed competitive inhibitions. The
oncentrations of inhibitors leading to a reduction of 50% in the initial
olymerase activity (IC50 values) were calculated from the inhibition
urves. The IC50 values were calculated each from at least three
ndependent experiments.us studies have shown that the response of RTs to NEM rs similar to the response to other thiol-specific reagents:
onsequently, NEM can serve as a typical thiol reagent
Hizi et al., 1991b, 1992). The results described in Fig. 4B
how that all activities of BLV RT are inhibited by NEM.
he IC50 value for RDDP activity is ;0.6 mM and for the
DDP function is ;1.5 mM NEM. As found previously for
ther RTs, the RNase H activity is more sensitive to NEM
han the DNA polymerase activities, i.e., the IC50 value is
0.15 mM. These results strongly suggest that reduced
ysteine groups are essential for all activities of BLV RTs.
his conclusion could be expected in view of the amino
cid sequence of BLV RT. The 584-residue-long polypep-
ide of the recombinant BLV RT contains five cysteine
esidues.
Effects of the Zn12 chelator orthophenanthroline (OP)
n BLV RT. Many DNA polymerases as well as all RTs
tudied were documented to be Zn12 metalloenzymes
ecause they are inhibited by the specific chelator OP. It
s apparent that BLV RT is also sensitive to OP, with
Nase H function less sensitive than the DNA polymer-
se activity (where the RDDP activity is more susceptible
han the DDDP function; see Fig. 4C). Similar patterns of
nhibition (in the order of sensitivity of RDDP . DDDP .
Nase H) were observed for other recombinant RTs (i.e.,
hose of HIV-1, HIV-2, EIAV, and MMTV), suggesting a
imilar involvement of Zn12 in their catalytic activities
Hizi et al., 1991b; Rubinek et al., 1994; Taube et al., 1998).
n fact, the RNase H activity of MMTV, HIV-1, and HIV-2
Ts is fully resistant to OP, up to ;6 mM OP. This led us
o the suggest that these RTs bind at least two Zn12
toms. The first one, which is more accessible to OP, is
nvolved in the DNA polymerase activity. The other atom,
hich is mainly involved in the RNase H function, binds
he protein more tightly and, consequently, is chelated at
igher OP concentrations (Hizi et al., 1991b; Taube et al.,
998). It is possible that this general scheme is also
elevant to BLV RT.
DISCUSSION
In contrast to the reverse transcriptases of lentiviruses
i.e., HIV-1, HIV-2, and EIAV), type C retroviruses (i.e.,
LV), and type B retroviruses (i.e., MMTV), the recombi-
ant expression and structure-function relationship of
he RTs of the BLV/HTLV subgroup of retroviruses were
ever studied until very recently. The present paper de-
cribes the expression and biochemical analyses of the
LV enzyme. The strategy for constructing the BLV RT-
oding gene, described in the present publication, as-
umes that this RT is a transframe protein (Fig. 1A). The
mino terminus of BLV RT is adjacent to the carboxyl
erminal residue of the mature viral protease (Rice et al.,
985; Yoshinka et al., 1986) and is coded by the last 26
odons of the pro gene open reading frame (followed by
he pol gene codons). This implies that a 26-amino-acid
esidue peptide identical to the amino terminal 26 resi-
t
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184 PERACH AND HIZIFIG. 4. Effects of NaCl, KCl, NEM, and the zinc chelator OP on the catalytic activities of BLV RT. The various enzymatic activities of BLV RT were
ested with increasing concentrations of NaCl or KCl (A), NEM (B), or OP (C). The RT activities were assayed as described under Materials and
ethods in the presence of increasing concentrations of NaCl, KCl, NEM, or OP and presented as the enzymatic activities relative to controls with
o inhbitors present. When NEM was used, the RT was preincubated with NEM on ice for 30 min before adding the appropriate substrate and
ssaying the specified activities. (A) Open symbols are for NaCl and closed ones for KCl: E, F, RDDP; h, n, DDDP; , , RNase H. (B and C) E, RDDP;
, DDDP; , RNase H.
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185RECOMBINANT BOVINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASEue sequence of BLV RT is released after the Gag-Pro
olyprotein precursor is cleaved by the viral protease in
he maturating virions. Based on this supposition, we
ostulate that such a peptide is likely to be found in
irions of BLV. It is interesting to note that this sequence
s proline rich; i.e., 7 of the 26 residues are prolines,
ncluding two sets of double prolines (Fig. 1A). Because
rolines are known to terminate a helixes and promote
urns, the presence of the prolines in this amino terminal
equence (and, more importantly, the presence of two
ets of double prolines) might be very significant for the
roper folding and enzymatic properties of BLV RT. We
lan to study the involvement of these proline clusters in
he structure-function relationships in BLV RT as done by
s previously for the highly conserved two sets of double
rolines found in HIV-1 RT (Hizi and Shaharabany, 1992).
n addition we plan to study the virus-derived BLV RT to
heck whether it is also a transframe protein and how
imilar is the recombinant protein to the viral RT.
When this research was near its completion, two very
ecent reports were published on the expression of RT of
TLV-1, which is related to BLV. In the first one, the
nzymatically active HTLV-1 RT expressed in bacteria
as coded for by the pol gene of the MT-2 isolate,
tarting with proline 33 in the pol reading frame. The
odon for this proline is located within the putative pro-
ol frameshift site (Owen et al., 1998). In the second
eport, the amino terminus of the HTLV-1 RT is derived
FIG. 4rom codons of the pro gene followed by sequences of the pol gene after adding an extra C in the putative
rameshift site to account for the frameshifting event
Trentin et al., 1998). This strategy of gene construction is
imilar to that employed for BLV RT in the present study
ith the exception that the pro-derived sequences do not
xtend in the case of HTLV-1 RT until the pro gene stop
odon (as done in our study) because the putative frame-
hift site in HTLV-1 is located upstream to this termina-
ion codon. In the latter study of HTLV-1 RT expression,
he amino terminus for the RT is, as in our study, adjacent
o the carboxyl terminus of the protease; however, since
rentin et al. assumed that the HTLV-1 RT sequence is
imilar to that of the RT of avian sarcoma virus (ASV).
hey have constructed an oligomeric structure of the RT,
.e., RT/RT–IN (which resembles the a/b subunits, re-
pectively, of ASV RT) and claim to have obtained, as
olely enzymatically active RT form, the a3/b tetramer.
his is apparently a molecular arrangement never en-
ountered before in RTs (Skalka and Goff, 1993; Coffin et
l., 1997; Hizi and Joklik, 1997). Taken together, there are
ubstantial discrepancies between the two published
eports on recombinant HTLV-1 RT. It is apparent from
ur study of BLV RT that the amino acid sequence re-
uirements and molecular arrangements of the recom-
inant BLV RT are substantially different from those of
oth HTLV-1 RT studies. These unique differences for
elatively close RTs should be helpful to future studies
esigned to study structure-function relationships of
inuedhese RTs.
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186 PERACH AND HIZIThe biochemical studies of the partially purified re-
ombinant BLV RT reveal a similarity to other previously
tudied RTs. The enzyme possesses all the known ac-
ivities of RTs and like most RTs prefers Mg12 over Mn12
s divalent cations required for the catalytic activities. A
omparison between the biochemical properties of the
ecombinant BLV RT and the RT activity in BLV virions
Gilden et al., 1975; Mamoun et al., 1981; Demirhan et al.,
996) is not straightforward because only a few biochem-
cal features were studied for the RT in crude viral ly-
ates. All BLV RT preparations prefer Mg12 over Mn12 for
atalysis. In one study (Demirhan et al., 1996), the mo-
ecular weight of the crude viral RT was determined to be
f ;80 kDa, and the enzyme was shown to have some
reference for poly(rC) z oligo(dG) over poly(rA) z oligo(dT)
s substrates for the RDDP activity. Because of the rel-
tively low accuracy of the method employed for the
olecular weight determination of the viral RT, it is fair to
onclude that the figure of ;80 kDa is not very different
rom the molecular weight of the monomeric recombi-
ant BLV RT obtained in our study (;65 kDa). However,
he substrate preference is clearly different from the one
ound in our study, where poly(rA) z oligo(dT) is better
han poly(rC) z oligo(dG) (see Table 2). This dissimilarity
hould be further investigated.
There are several unique features that set the novel
ecombinant BLV RT apart from most other RTs studied
o far. As discovered recently for MMTV RT (Taube et al.,
998), BLV RT is capable of being catalytically active as
monomer even after binding to nucleic acids. Unlike
LV RT, such a binding does not convert the BLV RT
rotein to homodimers. This feature cannot be attributed
o the recombinant expression system because most RTs
xpressed by us using the same system, (i.e., those of
IV-1, HIV-2, and EIAV) were dimers (Hizi et al., 1988,
991a; Shaharabany et al., 1993), whereas MLV RT was a
onomer (Hizi and Hughes, 1988). Moreover as men-
ioned above, a study on virus-derived BLV RT suggested
molecular weight of ;80 kDa, certainly closer to mono-
ers (of ;65 kDa) than to potential dimers (of ;130 kDa)
Demirhan et al., 1996). The sensitivity to salts, NaCl and
Cl, is also quite unique to BLV RT. Here again this
ingular property was also reported for MMTV RT (Taube
t al., 1998). The question that arises from both outlined
nique properties obviously is whether there is any con-
ection between the monomeric behavior of the active
T and the fact that its catalytic activities are salt sensi-
ive. A mechanistic study toward addressing this ques-
ion might be highly important in explaining the dimer-
zation process in retroviral RTs and its involvement in
atalysis. Recent studies have tried to localize amino
cid sequences responsible for dimerization and to an-
lyze the kinetics of the polymerization process in HIV RT
nd EIAV RT (Divita et al., 1995; Wohrl et al., 1997; Sou-
uet et al., 1998). However, it is not clear yet how this
rocess affects enzymatic activity. Future crystal studies sf BLV or MMTV RTs should shed light on the folding of
onomeric RTs in comparison with the folding patterns
f dimeric RTs, such as HIV-1 RT or MLV RT (Kohlstaedt
t al., 1992; Georgiadis et al., 1995; Jacobo Molina et al.,
993; Huang et al., 1998).
The purification pattern of the recombinant RT from the
acterial lysates (Table 1) suggests removal of strong
nhibitors because the overall activity goes up through-
ut the purification steps. We have observed a similar
henomenon while purifying recombinant MMTV RT
Taube et al., 1998). Interestingly, we have never encoun-
ered such an increase in the total activity while purifying
ecombinant RTs of HIV-1, HIV-2, or EIAV from similar
acterial extracts (unpublished data), suggesting a
omewhat specific inhibition of only MMTV and BLV RTs.
The sensitivity of RTs to nucleoside analogues is well
stablished, and several of the most common drugs
gainst HIV infections in humans, such as AZT, 3TC, and
dI, take advantage of the high susceptibility of HIV RT to
uch drugs. Generally speaking, the RTs can be divided
nto two major groups depending on the extent of this
ensitivity. The first one includes the highly sensitive RTs
f HIV-1, HIV-2 feline immunodeficiency virus (FIV) and
MTV (Hizi et al., 1991; De Clercq, 1995; North and
aCasse, 1995; Taube et al., 1998). The second group of
he less sensitive RTs include RTs of mammalian type C
etroviruses (such as MLV) and EIAV (Hizi et al., 1988;
ubinek et al., 1994; Coffin et al., 1997). The present study
ndicates that BLV RT belongs to the second group.
here are numerous studies on the involvement of dif-
erent amino acid residues of HIV-1 and HIV-2 RTs in this
ensitivity to drugs (e.g., Skalka and Goff, 1993; Perach et
l., 1995; Coffin et al., 1997). All of them were performed
y lowering the high sensitivity of the wild-type RTs by
odifying selective residues, thus leading to drug resis-
ance. However, there are no extensive studies on con-
erting wild-type RTs with low sensitivity levels to vari-
nts with high sensitivities by using a similar mutagen-
sis approach. BLV RT can serve for such structure-
unction mutagenesis studies in the future.
The sensitivity of RTs to chemical modifying com-
ounds such as sulfhydryl reagents is also useful in
tudying the biochemistry of these enzymes. All RT stud-
ed show some sensitivity to NEM. HIV-1 and HIV-2 RTs
re the only ones that show NEM-resistant DNA poly-
erase activities and, yet, have a highly sensitive RNase
activity (Hizi et al., 1988). Interestingly, none of the two
r three cysteine residues present in these RTs (in HIV-1
T, and HIV-2 RT, respectively) are located in the RNase
subdomain. All other RTs studied show a sensitivity to
EM in both DNA polymerase and RNase H functions.
LV RT belongs to this group of RTs (Fig. 4B). Still, as in
IV RTs, all five cysteines, of BLV RT are located outside
he putative RNase H subdomain. Therefore it is not
urprising that the DNA polymerase of BLV RT is NEM
ensitive. It is not fully clear, however, why the RNase H
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187RECOMBINANT BOVINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASEctivity is sensitive. As already speculated for HIV RTs,
his certainly reflects a tight interplay between the DNA
olymerase and RNase H domains of BLV RT as well.
uture three dimensional studies of BLV RT as well as
ther RTs will probably resolve this question.
MATERIALS AND METHODS
lasmids and enzymes
The RTs used in this study are recombinant enzymes
xpressed in E. coli DH5a and purified from the bacterial
xtracts. The BLV RT coding gene was derived from a
BR322 plasmid containing a BLV provirus (as SacI in-
ert introduced into the PstI site of the plasmid), which
as a generous gift of Dr. L. Willems of the Faculte’ des
ciences Agronomiques in Gembloux, Belgium. The se-
uence of this BLV provirus was published (Rice et al.,
985), and the numbering of the DNA sequences was
one according to this published sequence. The RT-
ncoding gene was subcloned into the expression plas-
id pUC12N, which differs from the original pUC12 in
hat the sequence flanking the lacZ initiator ATG codon
as modified to accommodate an NcoI restriction site.
his plasmid was already used by us for a constitutive
verexpression of a variety of recombinant RTs in bac-
eria (Hizi et al., 1988, 1991a; Hizi and Hughes, 1998;
aube et al., 1998). Recombinant HIV-1 RT was ex-
ressed in bacteria and purified as described (Hizi et al.,
988; Clark et al., 1990).
onstruction of BLV RT expression plasmids
All BLV-related DNA segments that were incorporated
nto the pUC12N expression plasmid were generated by
CR, using thermostable Vent DNA polymerase (NEB)
nd the BLV proviral DNA as a template. The sequences
nd localization on the BLV genome, the synthetic DNA
rimers used in the different PCR reactions, as well as
he proteins expressed, are all described under Results.
he DNA segments were digested with NcoI and HindIII
nd ligated into pUC12N plasmids, which were then
ntroduced into competent cells of the DH5a strain of E.
oli by transformation. Bacterial transformation, growth,
he analysis of the bacterial proteins by sodium dodecyl
ulfate polyacrylamide gel electrophoresis (SDS–PAGE),
nd the enzymatic assay for RDDP in bacterial lysates
ere all described in detail previously (Hizi and Hughes,
988; Hizi et al., 1988, 1991a).
ssays of the DNA polymerase and RNase H
ctivities
All enzymatic reactions were performed basically as
escribed previously (Hizi et al., 1991b; Rubinek et al.,
994; Taube et al., 1998). RDDP activity was routinely
ssayed by following the poly(rA)n z oligo(dT)12–18-directed
3ncorporation of [ H]dTTP into DNA. Assays were con- bucted, unless otherwise stated, in 25 mM Tris–HCl, 8
M MgCl2, 2 mM dithiothreitol (DTT), 5 mg/ml poly(rA)n z
ligo(dT)12–18 (Pharmacia), 5 mM [
3H]dTTP (specific radio-
ctivity 2000–4000 CPM/pmol) at a final pH of 8.0. Incu-
ation was performed for 30 min at 37°C (or 10 min for
he kinetic studies). In several experiments, we have
sed for assaying the RDDP activity poly(rC)n z oli-
o(dG)12–18 and [
3H] dGTP replacing poly(rA)n z oli-
o(dT)12–18 and [
3H]dTTP, respectively. The DDDP activity
as assayed under similar conditions with herring
perm activated DNA as the template-primer, [prepared
y a limited digestion with bovine pancreatic DNase I
Sigma), as described in detail previously (Shaharabany
nd Hizi, 1991)], suppliment by all four dNTPs (of which
nly one, dTTP, was radioactively labeled). RNase H
ctivity was assayed by measuring the hydrolytic release
f the radioactively labeled molecules from [3H]poly(rA)
Amersham) annealed to poly(dT)n (Pharmacia) into the
richloroacetic acid-soluble (TCA) fraction. The assay
as performed at pH 8.0 in a final volume of 100 ml
ontaining 50 mM Tris–HCl, 50 mM KCl, 8 mM MgCl2, 2.5
M DTT, and ;100 pmol of [3H] poly(rA)n z poly(dT)n. The
nzymatic activities were defined as follows: one unit of
NA polymerase activity is the amount of enzyme cata-
yzing the incorporation of 1 pmol of dNTP into DNA
roduct after 30 min at 37°C under standard assay con-
itions. One unit of RNase H activity is the amount of
nzyme catalyzing the release of 1 pmol of AMP in 30
in at 37°C under the assay conditions.
rotein purification of BLV RT
We have transferred the RT coding DNA insert into the
xpression plasmid pUC12N6H, which codes for a six-
istidine tag at the amino terminus of the recombinant
rotein. The transformed bacteria were grown at 37°C in
n NZYM medium containing 100 mg/ml ampicillin. After
4 h of growth, the E. coli culture was used to inoculate
freshly-prepared 0.5-liter culture of the same medium
upplemented by 50 mg/ml ampicillin. This culture was
rown for 12–16 h at 37°C, and the cells were harvested
y centrifugation at 12,000 g for 15 min at 4°C. The
elleted cells were washed three times with ice-cold
NE buffer (10 mM Tris–HCl, 1 mM EDTA, 150 mM NaCl,
H 8.0) and stored at 270°C until the purification.
Preparation of crude lysates. All purification steps
ere conducted at 4°C. The frozen cells were lysed for
5 min with lysis buffer (50 mM NaCl, 20 mM HEPES–
aOH, 1 mM PMSF, pH 7.0, containing 0.5 mg/ml ly-
ozyme at the ratio of 2 ml buffer per gr of wet bacteria).
fter 15 min on ice, NaCl was added to a final concen-
ration of 0.5 M and sonicated repeatedly on ice for a
otal of 5 min. Then polyethylene glycol at a final con-
entration of 0.3% was added and after stirring 15 min on
ce. The cell debris and nucleic acids were precipitated
y centrifuging for 40 min at 8000 g at 4°C.
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188 PERACH AND HIZINi21 nitriloacetic acid (Ni–NTA) agarose affinity chro-
atography. The supernatant was collected and diluted
:1 with loading buffer (20 mM HEPES–NaOH, 0.5M
aCl, final pH 7.8). The Ni–NTA agarose column (Qiagen)
as prewashed thoroughly with the same equilibration
uffer. The bacterial extracts were loaded on the column
nd washed extensively with the same buffer. The col-
mn was further washed with 50 mM ammonium ace-
ate, 0.3 M NaCl, pH 6.0, and the histidine-tagged protein
as eluted with the same buffer containing a 0–0.5 M
inear gradient of imidazole (adjusted to pH 6.0). Frac-
ions were collected, assayed for RDDP activity and
nalyzed by SDS–PAGE. Peak fractions were pooled and
ialyzed extensively against 20 mM Tris–HCl,10% (v/v)
lycerol, 25 mM NaCl, 0.1% (v/v) Triton X-100, 2 mM DDT,
nd 1 mM EDTA (final pH 7.5).
Carboxymethyl (CM)–Sepharose cation exchange
hromatography. The column was pre-equilibrated with
M buffer [10 mM sodium phosphate, 2 mM DTT, 10%
v/v) glycerol, pH 7.0] and then loaded with the dialyzed
aterial, followed by extensive washing with the same
uffer. The RT was eluted with the same buffer contain-
ng a 0–0.5 M linear gradient of NaCl in the same buffer.
eak reactions were pooled and dialyzed against 20 mM
ris–HCl (pH 8.0), 25 mM NaCl, 50% (v/v) glycerol, 0.2%
v/v) Triton X-100, 2 ml mM DTT, and 1 mM EDTA. The
urified RT was divided into aliquots and stored for long
eriods at 270°C and for routine analyses at 220°C.
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